Kestra Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Sell |
3,683
-1,222
| -25% | -$641K | 0.01% | 1090 |
|
|
2025
Q1 | $3.11M | Sell |
4,905
-1,835
| -27% | -$1.16M | 0.02% | 783 |
|
|
2024
Q4 | $4.8M | Buy |
6,740
+52
| +0.8% | +$37K | 0.03% | 592 |
|
|
2024
Q3 | $7.03M | Buy |
6,688
+533
| +9% | +$560K | 0.04% | 477 |
|
|
2024
Q2 | $6.47M | Buy |
6,155
+50
| +0.8% | +$52.6K | 0.04% | 500 |
|
|
2024
Q1 | $5.88M | Buy |
6,105
+1,167
| +24% | +$1.12M | 0.04% | 472 |
|
|
2023
Q4 | $4.34M | Buy |
4,938
+664
| +16% | +$583K | 0.04% | 505 |
|
|
2023
Q3 | $3.52M | Sell |
4,274
-17
| -0.4% | -$14K | 0.03% | 496 |
|
|
2023
Q2 | $3.08M | Sell |
4,291
-264
| -6% | -$190K | 0.03% | 533 |
|
|
2023
Q1 | $3.74M | Sell |
4,555
-1,777
| -28% | -$1.46M | 0.04% | 437 |
|
|
2022
Q4 | $4.57M | Buy |
6,332
+725
| +13% | +$523K | 0.04% | 470 |
|
|
2022
Q3 | $3.86M | Sell |
5,607
-383
| -6% | -$264K | 0.04% | 446 |
|
|
2022
Q2 | $3.54M | Sell |
5,990
-1,431
| -19% | -$846K | 0.04% | 465 |
|
|
2022
Q1 | $5.18M | Buy |
7,421
+943
| +15% | +$659K | 0.05% | 359 |
|
|
2021
Q4 | $4.09M | Sell |
6,478
-770
| -11% | -$486K | 0.04% | 426 |
|
|
2021
Q3 | $4.39M | Buy |
7,248
+452
| +7% | +$274K | 0.04% | 436 |
|
|
2021
Q2 | $3.8M | Buy |
6,796
+1,850
| +37% | +$1.03M | 0.04% | 435 |
|
|
2021
Q1 | $2.34M | Buy |
4,946
+1,855
| +60% | +$878K | 0.03% | 538 |
|
|
2020
Q4 | $1.48M | Buy |
3,091
+3,058
| +9,267% | +$1.46M | 0.02% | 701 |
|
|
2020
Q3 | $1.45M | Buy |
+33
| New | +$1.45M | 0.03% | 513 |
|